Roussakis Yiannis, Anagnostopoulos Georgios
Department of Medical Physics, German Oncology Center, Limassol, Cyprus.
Front Oncol. 2021 Nov 9;11:728452. doi: 10.3389/fonc.2021.728452. eCollection 2021.
The three-dimensional iridium-192 (Ir) high-dose-rate (HDR) brachytherapy manifests itself as a high-precision, hypofractionated, dose-escalating, minimally invasive method in the armamentarium of contemporary radiation oncology clinical applications. In this study, the physical aspects of the Ir radionuclide are presented. Its dosimetric application in HDR brachytherapy for different anatomical sites (prostate, gynecological malignancies, liver, and intrathoracic tumors) as well as the corresponding dosimetric comparison with the stereotactic body radiation therapy (SBRT) techniques based on a representative selection of dosimetric publications is reviewed and illustrated.
三维铱-192(Ir)高剂量率(HDR)近距离放射治疗在当代放射肿瘤学临床应用手段中表现为一种高精度、低分割、剂量递增的微创方法。在本研究中,介绍了铱放射性核素的物理特性。基于剂量学出版物的代表性选择,综述并举例说明了其在不同解剖部位(前列腺、妇科恶性肿瘤、肝脏和胸内肿瘤)的HDR近距离放射治疗中的剂量学应用,以及与立体定向体部放射治疗(SBRT)技术的相应剂量学比较。